NIH – MPP, COVID-19 Patent and Biological Material License Agreement Post author:GHIAA Admin Post published:June 29, 2022 Post category: Continue ReadingNIH – MPP, COVID-19 Patent and Biological Material License Agreement
Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement Post author:GHIAA Admin Post published:June 7, 2022 Post category: Continue ReadingEntasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
Elkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement Post author:GHIAA Admin Post published:May 27, 2022 Post category: Continue ReadingElkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement
BMGF – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement Post author:GHIAA Admin Post published:April 25, 2022 Post category: Continue ReadingBMGF – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement
Biological E – Dynavax Technologies, COVID-19 Vaccine Adjuvant Supply Agreement Post author:GHIAA Admin Post published:March 2, 2022 Post category: Continue ReadingBiological E – Dynavax Technologies, COVID-19 Vaccine Adjuvant Supply Agreement
Gavi Alliance – Novavax, COVID-19 Vaccine Advance Purchase Agreement Post author:GHIAA Admin Post published:February 1, 2022 Post category: Continue ReadingGavi Alliance – Novavax, COVID-19 Vaccine Advance Purchase Agreement
CEPI – Dynavax, COVID-19 Material Reservation Agreement Post author:GHIAA Admin Post published:January 28, 2022 Post category: Continue ReadingCEPI – Dynavax, COVID-19 Material Reservation Agreement
Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement Post author:GHIAA Admin Post published:December 21, 2021 Post category: Continue ReadingOcugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement
MSD – MPP, Molnupiravir License Agreement Post author:GHIAA Admin Post published:November 19, 2021 Post category: Continue ReadingMSD – MPP, Molnupiravir License Agreement